These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 30370500)
1. Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum. Melo TQ; Copray SJCVM; Ferrari MFR Neurochem Res; 2018 Dec; 43(12):2212-2223. PubMed ID: 30370500 [TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241 [TBL] [Abstract][Full Text] [Related]
3. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease. Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216 [TBL] [Abstract][Full Text] [Related]
4. A new role for α-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication. Guardia-Laguarta C; Area-Gomez E; Schon EA; Przedborski S Mov Disord; 2015 Jul; 30(8):1026-33. PubMed ID: 25952565 [TBL] [Abstract][Full Text] [Related]
5. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
6. Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease. Sironi L; Restelli LM; Tolnay M; Neutzner A; Frank S Cells; 2020 Jan; 9(1):. PubMed ID: 31963435 [TBL] [Abstract][Full Text] [Related]
7. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease. Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450 [TBL] [Abstract][Full Text] [Related]
8. α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca Paillusson S; Gomez-Suaga P; Stoica R; Little D; Gissen P; Devine MJ; Noble W; Hanger DP; Miller CCJ Acta Neuropathol; 2017 Jul; 134(1):129-149. PubMed ID: 28337542 [TBL] [Abstract][Full Text] [Related]
9. The Parkinson's disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release. Apicco DJ; Shlevkov E; Nezich CL; Tran DT; Guilmette E; Nicholatos JW; Bantle CM; Chen Y; Glajch KE; Abraham NA; Dang LT; Kaynor GC; Tsai EA; Nguyen KH; Groot J; Liu Y; Weihofen A; Hurt JA; Runz H; Hirst WD Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443159 [TBL] [Abstract][Full Text] [Related]
10. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease. Rekha KR; Inmozhi Sivakamasundari R Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137 [TBL] [Abstract][Full Text] [Related]
11. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease. Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886 [TBL] [Abstract][Full Text] [Related]
12. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies. Xilouri M; Brekk OR; Stefanis L Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776 [TBL] [Abstract][Full Text] [Related]
13. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease. Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262 [TBL] [Abstract][Full Text] [Related]
14. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer JA; Tardiff DF; Strathearn KE; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell KA; Bell GW; Fraenkel E; Cooper AA; Caldwell GA; McCaffery JM; Rochet JC; Lindquist S Dis Model Mech; 2010; 3(3-4):194-208. PubMed ID: 20038714 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. Devi L; Raghavendran V; Prabhu BM; Avadhani NG; Anandatheerthavarada HK J Biol Chem; 2008 Apr; 283(14):9089-100. PubMed ID: 18245082 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Rocha EM; De Miranda B; Sanders LH Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134 [TBL] [Abstract][Full Text] [Related]
18. Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders. Padilla-Godínez FJ; Ramos-Acevedo R; Martínez-Becerril HA; Bernal-Conde LD; Garrido-Figueroa JF; Hiriart M; Hernández-López A; Argüero-Sánchez R; Callea F; Guerra-Crespo M Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830348 [TBL] [Abstract][Full Text] [Related]
19. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. Liu Z; Yu Y; Li X; Ross CA; Smith WW Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271 [TBL] [Abstract][Full Text] [Related]